Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hdac3 regulates lymphovenous and lymphatic valve formation
Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi
Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi
View: Text | PDF
Research Article Development Vascular biology

Hdac3 regulates lymphovenous and lymphatic valve formation

  • Text
  • PDF
Abstract

Lymphedema, the most common lymphatic anomaly, involves defective lymphatic valve development; yet the epigenetic modifiers underlying lymphatic valve morphogenesis remain elusive. Here, we showed that during mouse development, the histone-modifying enzyme histone deacetylase 3 (Hdac3) regulates the formation of both lymphovenous valves, which maintain the separation of the blood and lymphatic vascular systems, and the lymphatic valves. Endothelium-specific ablation of Hdac3 in mice led to blood-filled lymphatic vessels, edema, defective lymphovenous valve morphogenesis, improper lymphatic drainage, defective lymphatic valve maturation, and complete lethality. Hdac3-deficient lymphovenous valves and lymphatic vessels exhibited reduced expression of the transcription factor Gata2 and its target genes. In response to oscillatory shear stress, the transcription factors Tal1, Gata2, and Ets1/2 physically interacted with and recruited Hdac3 to the evolutionarily conserved E-box–GATA–ETS composite element of a Gata2 intragenic enhancer. In turn, Hdac3 recruited histone acetyltransferase Ep300 to form an enhanceosome complex that promoted Gata2 expression. Together, these results identify Hdac3 as a key epigenetic modifier that maintains blood-lymph separation and integrates both extrinsic forces and intrinsic cues to regulate lymphatic valve development.

Authors

Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi

×

Figure 2

Hdac3 is an important regulator of lymphovenous valve development.

Options: View larger image (or click on image) Download as PowerPoint
Hdac3 is an important regulator of lymphovenous valve development.
(A–C)...
(A–C) Schematic model depicting normal anatomy of a developing murine lymphovenous valve (A, black arrow) in transverse (B) and coronal (C) planes. (D) Transverse sections of E14.5 Hdac3TekKO embryos revealed blood-filled lymph sacs (orange arrows) lined by lymphatic (Lyve1 immunostaining [red], white arrows), but not venous (Emcn immunostaining, green), endothelial cells compared with that seen in controls. (E) Dissected P5 Hdac3Cdh5KO mice had a blood-filled thoracic duct (green arrow) compared with a chyle-filled thoracic duct in control mice (black arrow). (F) H&E-stained coronal sections of an E13.5 Hdac3TekKO embryo revealed a blood-filled lymph sac (orange arrow) and disrupted morphology of the lymphovenous valves (green arrows) compared with controls (yellow arrows). Immunofluorescence staining for podoplanin (Pdpn) (green) and Lyve1 (red) showed overlapping expression (yellow) in E13.5 LVVs. Orange arrow indicates a blood-filled lymph sac. (G and H) H&E-stained coronal sections of E17.5 Hdac3Cdh5KO (G) and Hdac3Lyve1KO (H) embryos revealed disrupted morphology of the lymphovenous valves (blue arrows) compared with controls (green arrows). Orange arrow shows a blood-filled lymph sac. Lyve1 (red) was expressed in E17.5 murine lymphovenous valves (G and H). Emcn (green, venous marker) was used as a negative control for lymphovenous valves (H). IJV, internal jugular vein; LS, lymph sac; LVV, lymphovenous valve; SVC, superior vena cava; TD, thoracic duct. Scale bars: 100 μm and 50 μm (F, bottom panels, G, and H). See also Supplemental Figure 5 and Supplemental Table 5.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts